Evaluation of Disease-Free Survival as an Intermediate Metric of Overall Survival in Patients With Localized Renal Cell Carcinoma: A Trial-Level Meta-Analysis
Cancer - United States
doi 10.1002/cncr.31154
Full Text
Open PDFAbstract
Available in full text
Date
December 19, 2017
Authors
Publisher
Wiley